Zai Lab expects Zoci Phase III enrollment completion in first half of 2027, while targeting first FDA BLA in late 2027
Zai Lab Limited American Depositary Shares · PHARMACEUTICAL PREPARATIONS · Now $17.09
+10% in 3d after detection
Post-detection moves
1h
—
1d
+5.3%
3d
+10%
7d
-1.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS